Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 21, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Universal Health Services, Inc. (UHS) has a Wall Street consensus price target of $245.67, based on estimates from 43 covering analysts. With the stock currently trading at $206.10, this represents a potential upside of +19.2%. The company has a market capitalization of $3M.
Analyst price targets range from a low of $219.00 to a high of $274.00, representing a 22% spread in expectations. The median target of $242.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 18 analysts rating the stock as a Buy or Strong Buy,23 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, UHS trades at a trailing P/E of 8.9x and forward P/E of 8.8x. The forward PEG ratio of 0.55 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +1.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $323.90, with bear and bull scenarios of $185.29 and $422.28 respectively. Model confidence stands at 79/100, indicating high predictability in the company's fundamentals.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how UHS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonUniversal Health Services, Inc. (UHS) has a consensus 12-month price target of $245.67, implying 19.2% upside from $206.1. The 43 analysts covering UHS see moderate appreciation potential.
UHS has a consensus rating of "Hold" based on 43 Wall Street analysts. The rating breakdown is mixed, with 23 Hold ratings making up the largest segment. The consensus 12-month price target of $245.67 implies 19.2% upside from current levels.
With a forward P/E of 8.7976x, UHS trades at a relatively low valuation. The consensus target of $245.67 implies 19.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $274 for UHS, while the most conservative target is $219. The consensus of $245.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $422 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UHS is heavily covered by Wall Street, with 43 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 23 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UHS stock forecast based on 43 Wall Street analysts shows a consensus price target of $245.67, with estimates ranging from $219 (bear case) to $274 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $324, with bear/bull scenarios of $185/$422.
Our quantitative valuation model calculates UHS's fair value at $324 (base case), with a bear case of $185 and bull case of $422. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 79/100.
UHS trades at a forward P/E ratio of 8.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 8.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on UHS, with a "Hold" consensus rating and $245.67 price target (19.2% upside). 18 of 43 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UHS analyst price targets range from $219 to $274, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $245.67 consensus represents the middle ground. Our model's $185-$422 range provides an independent fundamental perspective.